Concepedia

Coding joint: kappa-deleting recombination excision circle ratio and B cell activating factor level: predicting juvenile dermatomyositis rituximab response, a proof-of-concept study

Elisa Ochfeld, Victoria Hans, Wil Marin, Najah Ahsan, Gabrielle Morgan, Lauren M. Pachman, Amer Khojah

BMC Rheumatology · 2022 · 14 citations · 9 references

Open access

References

9

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

Chester V. Oddis, Ann M. Reed, Rohit Aggarwal et al. · Arthritis & Rheumatism · 2012 · 669 citations

Autoantibodies in myositis

Neil McHugh, Sarah Tansley · Nature Reviews Rheumatology · 2018 · 367 citations

Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion

Menno C. van Zelm, Tomasz Szczepański, Mirjam van der Burg et al. · The Journal of Experimental Medicine · 2007 · 283 citations · Full text

Predictors of Clinical Improvement in Rituximab‐Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis

Rohit Aggarwal, Andriy I. Bandos, Ann M. Reed et al. · Arthritis & Rheumatology · 2013 · 274 citations · Full text

Disease activity score for children with juvenile dermatomyositis: Reliability and validity evidence

Rita Bode, Marisa S. Klein‐Gitelman, Michael L. Miller et al. · Arthritis Care & Research · 2003 · 257 citations